Propanc Biopharma signs MOU with Avance Clinical for Phase 1 trial
Go back to Propanc Biopharma signs MOU with Avance Clinical for Phase 1 trial| (NASDAQ: PPCB) | Delayed: 1.03 +0.02 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.01 | 52 Week High | $ | |||
| Open | $1.02 | 52 Week Low | $ | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $0.99 | EPS | $ | |||
| Volume | 175,632 | |||||
